Sino Biopharmaceutical (SBMFF) Short Interest Ratio & Short Volume → $5,000 Gold? (From Stansberry Research) (Ad) Free SBMFF Stock Alerts $0.31 0.00 (0.00%) (As of 05/2/2024 ET) Add Compare Share Share Short InterestStock AnalysisChartFinancialsHeadlinesSEC FilingsShort InterestStock AnalysisChartFinancialsHeadlinesSEC FilingsShort Interest Sino Biopharmaceutical Short Interest DataCurrent Short Volume15,423,100 sharesPrevious Short Volume5,308,700 sharesChange Vs. Previous Month+190.52%Dollar Volume Sold Short$5.90 millionShort Interest Ratio / Days to Cover19,278.9Last Record DateApril 15, 2024Outstanding Shares18,813,870,000 sharesPercentage of Shares Shorted0.08%Today's Trading Volume0 sharesAverage Trading Volume250 sharesToday's Volume Vs. Average0% Short Selling Sino Biopharmaceutical ? Sign up to receive the latest short interest report for Sino Biopharmaceutical and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatSBMFF Short Interest Over TimeSBMFF Days to Cover Over TimeSBMFF Percentage of Float Shorted Over Time Ad Stansberry ResearchGlobal crypto currency reset (41 major banks signed up)Behind closed doors, at least 41 major US banks have signed up to a strange new crypto project... Here's everything you need to know. Sino Biopharmaceutical Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/202415,423,100 shares $5.90 million +190.5%N/A19278.9 $0.38 3/31/20245,308,700 shares $1.84 million +0.0%N/A10617.4 $0.35 3/15/20245,306,700 shares $1.92 million -5.1%N/A0 $0.36 2/29/20245,588,700 shares $2.03 million -48.3%N/A553.3 $0.36 2/15/202410,809,700 shares $3.70 million -68.8%N/A108097 $0.34 1/15/20245,514,700 shares $2.29 million -0.3%N/A0 $0.42 Get the Latest News and Ratings for SBMFF and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Sino Biopharmaceutical and its competitors with MarketBeat's FREE daily newsletter. 12/31/20235,533,000 shares $2.30 million +43.1%N/A32168.5 $0.42 12/15/20233,867,600 shares $1.49 million +1.7%N/A19338 $0.38 11/30/20233,804,400 shares $1.88 million +2.3%N/A0 $0.49 11/15/20233,718,500 shares $1.84 million -79.2%N/A1430.2 $0.49 10/31/202317,838,400 shares $5.89 million +3.8%N/A44596 $0.33 10/15/202317,182,200 shares $5.90 million +13.9%N/A21477.8 $0.34 9/30/202315,090,700 shares $5.13 million +58.6%N/A5389.5 $0.34 9/15/20239,517,500 shares $3.52 million +3.7%N/A0 $0.37 8/31/20239,174,500 shares $3.39 million +131.9%N/A4432.1 $0.37 8/15/20233,955,800 shares $1.56 million -38.0%N/A1798.1 $0.40 7/31/20236,383,200 shares $2.87 million -37.6%N/A1877.4 $0.45 7/15/202310,224,700 shares $4.40 million -13.2%N/A1704.1 $0.43 6/30/202311,784,600 shares $4.61 million +44.3%N/A19641 $0.39 6/15/20238,168,200 shares $3.84 million +52.9%N/A4804.8 $0.47 5/31/20235,342,200 shares $2.62 million -3.8%N/A574.4 $0.49 5/15/20235,554,200 shares $2.89 million -3.8%N/A5554.2 $0.52 4/30/20235,774,400 shares $3.14 million +29.4%N/A57744 $0.54 4/15/20234,461,200 shares $2.50 million -51.8%N/A874.7 $0.56 3/31/20239,264,000 shares $4.82 million -12.6%N/A0 $0.52 3/15/202310,603,300 shares $5.51 million +9.8%N/A4418 $0.52 2/28/20239,657,100 shares $5.36 million +228.5%N/A4023.8 $0.56 2/15/20232,939,600 shares $1.64 million +101.6%N/A3674.5 $0.56 1/31/20231,458,000 shares $815,313.60 +14.5%N/A633.9 $0.56 1/15/20231,273,100 shares $802,053.00 -57.0%N/A40.5 $0.63 12/30/20222,957,800 shares $1.73 million -9.6%N/A394.4 $0.59 12/15/20223,271,300 shares $1.84 million -19.8%N/A1022.3 $0.56 11/30/20224,076,700 shares $2.27 million -2.7%N/A3397.3 $0.56 11/15/20224,187,900 shares $2.35 million +9.2%N/A1102.1 $0.56 10/31/20223,836,100 shares $1.90 million +49.9%N/A892.1 $0.50 10/15/20222,558,900 shares $1.20 million -11.4%N/A1705.9 $0.47 9/30/20222,888,900 shares $1.27 million -34.5%N/A1203.7 $0.44 9/15/20224,411,900 shares $2.10 million -30.3%N/A1470.6 $0.48 8/31/20226,326,700 shares $3.61 million +2.8%N/A266.9 $0.57 8/15/20226,153,100 shares $3.32 million -2.2%N/A30765.5 $0.54Urgent Nvidia Warning (Ad)Could Steve Job's 'Final Prophecy' Make You Rich? Just before he died, Steve Jobs issued a "Final Prophecy" that's now coming true... and making some people rich. In one recent 90-day stretch, 50 companies related to Jobs' "Final Prophecy" soared by 100% or more. What was Steve Jobs' last big prediction, and how can you get in on it? Professor Joel Litman explains everything... including the surprising group of stocks moving higher, and his No. 1 favorite stock in this space.Click here to access… SBMFF Short Interest - Frequently Asked Questions What is Sino Biopharmaceutical's current short interest? Short interest is the volume of Sino Biopharmaceutical shares that have been sold short but have not yet been closed out or covered. As of April 15th, investors have sold 15,423,100 shares of SBMFF short. Learn More on Sino Biopharmaceutical's current short interest. What is a good short interest ratio for Sino Biopharmaceutical? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. SBMFF shares currently have a short interest ratio of 19,279.0. Learn More on Sino Biopharmaceutical's short interest ratio. Is Sino Biopharmaceutical's short interest increasing or decreasing? Sino Biopharmaceutical saw a increase in short interest in April. As of April 15th, there was short interest totaling 15,423,100 shares, an increase of 190.5% from the previous total of 5,308,700 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Sino Biopharmaceutical's short interest compare to its competitors? Here is how the short interest of companies in the sector of "medical" compare to Sino Biopharmaceutical: Aspen Pharmacare Holdings Limited (0.00%), Orion Oyj (0.00%), Hikma Pharmaceuticals PLC (0.79%), Ramsay Health Care Limited (0.00%), Zealand Pharma A/S (0.80%), GN Store Nord A/S (0.00%), Nihon Kohden Co. (0.00%), Sysmex Co. (0.00%), Eurofins Scientific SE (0.19%), Sandoz Group AG (0.51%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short Sino Biopharmaceutical stock? Short selling SBMFF is an investing strategy that aims to generate trading profit from Sino Biopharmaceutical as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Sino Biopharmaceutical? A short squeeze for Sino Biopharmaceutical occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of SBMFF, which in turn drives the price of the stock up even further. How often is Sino Biopharmaceutical's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including SBMFF, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: Aspen Pharmacare Short Squeeze Orion Oyj Short Squeeze Hikma Pharmaceuticals Short Squeeze Amplifon Short Squeeze Ramsay Health Care Short Squeeze Zealand Pharma A/S Short Squeeze GN Store Nord A/S Short Squeeze Nihon Kohden Short Squeeze Sysmex Short Squeeze Eurofins Scientific Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTCMKTS:SBMFF) was last updated on 5/3/2024 by MarketBeat.com Staff From Our PartnersThe AI stock to buy right nowStockEarningsCould Your Accounts Be Frozen?Allegiance GoldUrgent Nvidia WarningAltimetryThe A.I. story nobody is telling you (Read ASAP)TradeSmith$5,000 Gold?Stansberry ResearchBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressBill Gates is all about this tiny $2 stockTimothy SykesNew Trump BombshellThe Freeport Society